Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 115

1.

Erythropoietin attenuates acute kidney dysfunction in murine experimental sepsis by activation of the β-common receptor.

Coldewey SM, Khan AI, Kapoor A, Collino M, Rogazzo M, Brines M, Cerami A, Hall P, Sheaff M, Kieswich JE, Yaqoob MM, Patel NS, Thiemermann C.

Kidney Int. 2013 Sep;84(3):482-90. doi: 10.1038/ki.2013.118. Epub 2013 Apr 17.

PMID:
23594675
2.

Erythropoietin attenuates cardiac dysfunction in experimental sepsis in mice via activation of the β-common receptor.

Khan AI, Coldewey SM, Patel NS, Rogazzo M, Collino M, Yaqoob MM, Radermacher P, Kapoor A, Thiemermann C.

Dis Model Mech. 2013 Jul;6(4):1021-30. doi: 10.1242/dmm.011908. Epub 2013 Mar 15.

3.

β Common receptor integrates the erythropoietin signaling in activation of endothelial nitric oxide synthase.

Su KH, Shyue SK, Kou YR, Ching LC, Chiang AN, Yu YB, Chen CY, Pan CC, Lee TS.

J Cell Physiol. 2011 Dec;226(12):3330-9. doi: 10.1002/jcp.22678.

PMID:
21321940
4.

Inhibition of IκB kinase reduces the multiple organ dysfunction caused by sepsis in the mouse.

Coldewey SM, Rogazzo M, Collino M, Patel NS, Thiemermann C.

Dis Model Mech. 2013 Jul;6(4):1031-42. doi: 10.1242/dmm.012435. Epub 2013 May 2.

5.

Erythropoietin mediates tissue protection through an erythropoietin and common beta-subunit heteroreceptor.

Brines M, Grasso G, Fiordaliso F, Sfacteria A, Ghezzi P, Fratelli M, Latini R, Xie QW, Smart J, Su-Rick CJ, Pobre E, Diaz D, Gomez D, Hand C, Coleman T, Cerami A.

Proc Natl Acad Sci U S A. 2004 Oct 12;101(41):14907-12. Epub 2004 Sep 29.

6.

Erythropoietin prevents sepsis-related acute kidney injury in rats by inhibiting NF-κB and upregulating endothelial nitric oxide synthase.

Souza AC, Volpini RA, Shimizu MH, Sanches TR, Camara NO, Semedo P, Rodrigues CE, Seguro AC, Andrade L.

Am J Physiol Renal Physiol. 2012 Apr 15;302(8):F1045-54. doi: 10.1152/ajprenal.00148.2011. Epub 2012 Jan 11.

7.

Delayed administration of pyroglutamate helix B surface peptide (pHBSP), a novel nonerythropoietic analog of erythropoietin, attenuates acute kidney injury.

Patel NS, Kerr-Peterson HL, Brines M, Collino M, Rogazzo M, Fantozzi R, Wood EG, Johnson FL, Yaqoob MM, Cerami A, Thiemermann C.

Mol Med. 2012 May 9;18:719-27. doi: 10.2119/molmed.2012.00093.

8.

Tissue protection by erythropoietin: new findings in a moving field.

Nangaku M.

Kidney Int. 2013 Sep;84(3):427-9. doi: 10.1038/ki.2013.140.

PMID:
23989353
9.

Pharmacological preconditioning with erythropoietin attenuates the organ injury and dysfunction induced in a rat model of hemorrhagic shock.

Nandra KK, Collino M, Rogazzo M, Fantozzi R, Patel NS, Thiemermann C.

Dis Model Mech. 2013 May;6(3):701-9. doi: 10.1242/dmm.011353. Epub 2012 Dec 20.

10.

Amelioration of lipopolysaccharide-induced acute kidney injury by erythropoietin: involvement of mitochondria-regulated apoptosis.

Stoyanoff TR, Todaro JS, Aguirre MV, Zimmermann MC, Brandan NC.

Toxicology. 2014 Apr 6;318:13-21. doi: 10.1016/j.tox.2014.01.011. Epub 2014 Feb 20.

PMID:
24561306
11.

Protective role of peroxisome proliferator-activated receptor-β/δ in septic shock.

Kapoor A, Shintani Y, Collino M, Osuchowski MF, Busch D, Patel NS, Sepodes B, Castiglia S, Fantozzi R, Bishop-Bailey D, Mota-Filipe H, Yaqoob MM, Suzuki K, Bahrami S, Desvergne B, Mitchell JA, Thiemermann C.

Am J Respir Crit Care Med. 2010 Dec 15;182(12):1506-15. doi: 10.1164/rccm.201002-0240OC. Epub 2010 Aug 6.

PMID:
20693380
12.

Renoprotective effect of erythropoietin in ischemia/reperfusion injury: possible roles of the Akt/endothelial nitric oxide synthase-dependent pathway.

Oba S, Suzuki E, Nishimatsu H, Kumano S, Hosoda C, Homma Y, Hirata Y.

Int J Urol. 2012 Mar;19(3):248-55. doi: 10.1111/j.1442-2042.2011.02920.x. Epub 2011 Nov 29.

13.

AMP-activated protein kinase mediates erythropoietin-induced activation of endothelial nitric oxide synthase.

Su KH, Yu YB, Hou HH, Zhao JF, Kou YR, Cheng LC, Shyue SK, Lee TS.

J Cell Physiol. 2012 Aug;227(8):3053-62. doi: 10.1002/jcp.23052.

PMID:
22021095
14.

Effects of continuous erythropoietin receptor activator in sepsis-induced acute kidney injury and multi-organ dysfunction.

Rodrigues CE, Sanches TR, Volpini RA, Shimizu MH, Kuriki PS, Camara NO, Seguro AC, Andrade L.

PLoS One. 2012;7(1):e29893. doi: 10.1371/journal.pone.0029893. Epub 2012 Jan 3.

15.

Carbamylated erythropoietin protects the myocardium from acute ischemia/reperfusion injury through a PI3K/Akt-dependent mechanism.

Xu X, Cao Z, Cao B, Li J, Guo L, Que L, Ha T, Chen Q, Li C, Li Y.

Surgery. 2009 Sep;146(3):506-14. doi: 10.1016/j.surg.2009.03.022. Epub 2009 Jun 9.

PMID:
19715808
16.

Mesenchymal stem cells ameliorate sepsis-associated acute kidney injury in mice.

Luo CJ, Zhang FJ, Zhang L, Geng YQ, Li QG, Hong Q, Fu B, Zhu F, Cui SY, Feng Z, Sun XF, Chen XM.

Shock. 2014 Feb;41(2):123-9. doi: 10.1097/SHK.0000000000000080.

PMID:
24169208
17.

β Common Receptor Mediates Erythropoietin-Conferred Protection on OxLDL-Induced Lipid Accumulation and Inflammation in Macrophages.

Lee TS, Lu KY, Yu YB, Lee HT, Tsai FC.

Mediators Inflamm. 2015;2015:439759. doi: 10.1155/2015/439759. Epub 2015 May 25.

18.

Erythropoietin protects against cisplatin-induced nephrotoxicity by attenuating endoplasmic reticulum stress-induced apoptosis.

Kong D, Zhuo L, Gao C, Shi S, Wang N, Huang Z, Li W, Hao L.

J Nephrol. 2013 Jan-Feb;26(1):219-27. doi: 10.5301/jn.5000177.

PMID:
22711436
19.

Gene deletion of protein tyrosine phosphatase 1B protects against sepsis-induced cardiovascular dysfunction and mortality.

Coquerel D, Neviere R, Delile E, Mulder P, Marechal X, Montaigne D, Renet S, Remy-Jouet I, Gomez E, Henry JP, do Rego JC, Richard V, Tamion F.

Arterioscler Thromb Vasc Biol. 2014 May;34(5):1032-44. doi: 10.1161/ATVBAHA.114.303450. Epub 2014 Feb 27.

20.

A nonerythropoietic peptide that mimics the 3D structure of erythropoietin reduces organ injury/dysfunction and inflammation in experimental hemorrhagic shock.

Patel NS, Nandra KK, Brines M, Collino M, Wong WF, Kapoor A, Benetti E, Goh FY, Fantozzi R, Cerami A, Thiemermann C.

Mol Med. 2011 Sep-Oct;17(9-10):883-92. doi: 10.2119/molmed.2011.00053. Epub 2011 May 13.

Items per page

Supplemental Content

Write to the Help Desk